GrantZIABC
Growth Regulation Section
- Activity
- ZIA
- Institute
- BC
- Fiscal years
- 2015–2017
- Amount counted
- $498,048
These are registry fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Abstract public domain (NIH RePORTER)
We are collaborating with Serguei Kozlov (Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, MD) and Christine Alewine (LMB) to determine if mesothelin is needed for pancreatic cancer development or progression. To do this KPC mice, which develop pancreatic cancers, have been crossed with mesothelin -/- mice. KPC mice not making mesothelin have been obtained and are being followed for development of pancreatic cancer. If cancer develops we will then determine how long the mice live and if the cancer spreads.